MAGAGNOLI, LORENZA
MAGAGNOLI, LORENZA
Universita' degli Studi di MILANO
Beyond vessels and bones: can CKD-MBD treatment improve uremic subjects' minds?
2022 L. Magagnoli, A. Galassi, M. Cozzolino
COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic
2021 A. Galassi, L. Magagnoli, M. Cozzolino
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency
2021 A. Galassi, P. Ciceri, G. Porata, R. Iatrino, G. Boni Brivio, E. Fasulo, L. Magagnoli, A. Stucchi, M. Frittoli, A. Cara, M. Cozzolino
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
2022 P. Ciceri, V. Bono, L. Magagnoli, M. Sala, A. D'ARMINIO MONFORTE, A. Galassi, A. Barassi, G.C. Marchetti, M.G. Cozzolino
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns
2022 A. Galassi, A. Cara, L. Magagnoli, F.M. Faccioli, M. Cozzolino
Efficacy and safety of etelcalcetide in hemodialysis patients with moderate to severe secondary hyperparathyroidism
2022 P. Monciino, L. Magagnoli, E. Fasulo, M. Frittoli, C. Leotta, H.N. Pham, A. Stucchi, P. Ciceri, A. Galassi, M. Cozzolino
Forced diuresis oriented by point‐of‐care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma : The role of hepatic venogram: A case report
2021 A. Galassi, L. Magagnoli, E. Fasulo, A. Stucchi, E. Restelli, A. Moro, M. Violati, M. Cozzolino
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
2022 A. Galassi, P. Ciceri, V. Bono, L. Magagnoli, M. Sala, L. Artioli, R. Rovito, M. Hadla, V. Yellenki, A. D’Arminio Monforte, C. Tincati, M. Cozzolino, G. Marchetti
Measuring FGF23 in clinical practice: dream or reality?
2022 L. Magagnoli, A. Galassi, P. Ciceri, M. Cozzolino
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study
2020 P. Ciceri, G. Tettamanti, A. Galassi, L. Magagnoli, N. Fabresse, J. Alvarez, Z.A. Massy, P. Messa, M. Cozzolino
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound
2020 A. Galassi, F. Casanova, L. Gazzola, R. Rinaldo, M. Ceresa, E. Restelli, A. Giorgini, S. Birocchi, M. Giovenzana, U. Zoni, F. Valli, L. Massironi, S. Belletti, L. Magagnoli, A. Stucchi, M. Ippolito, S. Carugo, E. Parazzini, M. Cozzolino
The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects
2022 P. Ciceri, L. Artioli, L. Magagnoli, A. Barassi, J. Alvarez, Z.A. Massy, A. Galassi, M. Cozzolino